Daniel Ngui Selected Research

Osteoporosis

4/2014	Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.
3/2013	Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Ngui Research Topics

Disease

3	Stroke (Strokes) 01/2023 - 12/2020
2	Atrial Fibrillation 01/2022 - 12/2020
2	Chronic Renal Insufficiency 01/2021 - 11/2016
2	Atherosclerosis 01/2021 - 11/2016
2	Abdominal Aortic Aneurysm 01/2021 - 11/2016
2	Osteoporosis 04/2014 - 03/2013
1	Hypertriglyceridemia 01/2022
1	Embolic Stroke 01/2022
1	Patent Foramen Ovale 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hemorrhage 12/2020
1	Osteonecrosis (Kienbock's Disease) 04/2014
1	Postmenopausal Osteoporosis 03/2013
1	Osteoporotic Fractures 03/2013

Drug/Important Bio-Agent (IBA)

2	AnticoagulantsIBA 01/2022 - 12/2020
2	LDL CholesterolIBA 01/2021 - 11/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2016
2	Diphosphonates (Bisphosphonates)IBA 04/2014 - 03/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	N(4)-oleylcytosine arabinosideIBA 12/2020
1	CreatinineIBA 12/2020
1	Vitamin K FDA Link 12/2020
1	Raloxifene Hydrochloride (Evista)FDA Link 03/2013
1	Teriparatide (Parathar)FDA Link 03/2013
1	Hormones (Hormone)IBA 03/2013
1	Denosumab FDA Link 03/2013

Therapy/Procedure

5	Therapeutics 01/2022 - 03/2013
2	Secondary Prevention 01/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 12/2020 - 03/2013